Molecule intelOpportunity: Lower0Underserved

Isophane Insulin Human

4 brands · 2 companies · product forms

Opportunity snapshot

Launch attractiveness
33
Market saturation
6
Price room
0
Regulatory risk
0
4
brands
2
companies
Rs 1,158.44
median price
4
price points
1x
price spread
90
confidence %

Who competes here

Top companies by brand count — concentrated market · leader share 50%

Price room

Across observed sources and strengths
CheapestRs 1,158.44
MedianRs 1,158.44
Most expensiveRs 1,158.44
Spread1×
Sources: DRAP-official

Only 4 trusted price points; variation not scored (low data).

Why this score

Launch attractiveness

40% supply-gap(40) + 25% price-variation(0) + 20% low-competition(94) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

2 canonical companies and 4 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

Only 4 trusted price points; variation not scored (low data).

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Reduced by: no ATC code.

Packaged brief for this lower opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.